Northern Trust’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.3M Sell
566,408
-14,718
-3% -$515K ﹤0.01% 1794
2026
Q2
$24.9M Buy
581,126
+61,681
+12% +$2.3M ﹤0.01% 1666
2026
Q1
$20.9M Buy
519,445
+46,226
+10% +$1.99M ﹤0.01% 1658
2025
Q4
$24M Buy
473,219
+11,959
+3% +$425K ﹤0.01% 1549
2025
Q3
$13.4M Buy
461,260
+750
+0.2% +$17.3K ﹤0.01% 1937
2025
Q2
$10.8M Buy
460,510
+42,251
+10% +$950K ﹤0.01% 2025
2025
Q1
$10M Sell
418,259
-36,748
-8% -$1.18M ﹤0.01% 2032
2024
Q4
$19.2M Buy
455,007
+89,707
+25% +$3.97M ﹤0.01% 1714
2024
Q3
$16.1M Sell
365,300
-219
-0.1% -$8.31K ﹤0.01% 1768
2024
Q2
$13.2M Sell
365,519
-6,935
-2% -$275K ﹤0.01% 1828
2024
Q1
$16.1M Buy
372,454
+50,619
+16% +$1.8M ﹤0.01% 1741
2023
Q4
$4.95M Buy
321,835
+26,331
+9% +$334K ﹤0.01% 2526
2023
Q3
$4.05M Buy
295,504
+18,041
+7% +$310K ﹤0.01% 2568
2023
Q2
$4.45M Buy
277,463
+84,078
+43% +$759K ﹤0.01% 2568
2023
Q1
$1.5M Buy
193,385
+67,904
+54% +$524K ﹤0.01% 3069
2022
Q4
$2.43M Buy
125,481
+10,611
+9% +$192K ﹤0.01% 2890
2022
Q3
$2.45M Buy
114,870
+2,400
+2% +$44.9K ﹤0.01% 2908
2022
Q2
$1.53M Buy
112,470
+3,063
+3% +$53.4K ﹤0.01% 3200
2022
Q1
$2.57M Buy
109,407
+31,554
+41% +$679K ﹤0.01% 2966
2021
Q4
$2.08M Buy
77,853
+18,538
+31% +$410K ﹤0.01% 3205
2021
Q3
$1.03M Buy
+59,315
New +$1.06M ﹤0.01% 3543

Other funds holding VERA

Northern Trust's VERA Position: Q3 2026 in Review

Northern Trust reduced its Vera Therapeutics (VERA) stake by 2.5% in Q3 2026, selling an estimated $515K and leaving 566,408 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1794.

Northern Trust first reported a position in VERA in Q3 2021 and has held it in 21 quarters since. The position peaked at $24.9M in Q2 2026. 224 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Northern Trust held 566,408 shares of Vera Therapeutics worth $18.3M as of Q3 2026.
  • Northern Trust sold 14,718 Vera Therapeutics shares in Q3 2026, an estimated $515K.
  • Vera Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #1794 holding.
  • Northern Trust first reported a position in Vera Therapeutics in Q3 2021 and has held it in 21 quarters since.
  • Northern Trust's Vera Therapeutics position peaked at $24.9M in Q2 2026.
  • 224 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.